Spots Global Cancer Trial Database for skin lesions
Every month we try and update this database with for skin lesions cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | NCT02635789 | Tuberous Sclero... Angiofibroma Hypomelanotic M... Plaque | NPC-12G gel Placebo gel | 3 Years - | Nobelpharma | |
| A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin | NCT04059588 | Cancer Solid Tumor Cancer of Skin | 2141 V-11 | 18 Years - | Rockefeller University | |
| VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine | NCT01385943 | Skin Cancer Skin Lesions | 5 Years - | Lucid | ||
| Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses | NCT00814528 | Actinic Keratos... | 5-ALA plus Blu-... 5-FU, Imiquimod... | 18 Years - 95 Years | University of Chicago | |
| Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses | NCT00814528 | Actinic Keratos... | 5-ALA plus Blu-... 5-FU, Imiquimod... | 18 Years - 95 Years | University of Chicago | |
| Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging | NCT02056522 | Skin Lesions | 21 Years - 97 Years | Orlucent, Inc | ||
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
| Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging | NCT02056522 | Skin Lesions | 21 Years - 97 Years | Orlucent, Inc | ||
| Study of the Nevisense Device to Assess Atypical Skin Lesions | NCT04705168 | Nevus Multiple Nevi Large Acquired ... Skin Lesion | Nevisense elect... | 30 Years - | Memorial Sloan Kettering Cancer Center | |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
| VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine | NCT01385943 | Skin Cancer Skin Lesions | 5 Years - | Lucid | ||
| Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor | NCT00314262 | Precancerous Co... | Erlotinib & Cel... | 18 Years - 65 Years | Emory University | |
| Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex | NCT02634931 | Tuberous Sclero... Angiofibroma Hypomelanotic M... Plaque | NPC-12G gel | 3 Years - | Nobelpharma | |
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | NCT02635789 | Tuberous Sclero... Angiofibroma Hypomelanotic M... Plaque | NPC-12G gel Placebo gel | 3 Years - | Nobelpharma | |
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | NCT02635789 | Tuberous Sclero... Angiofibroma Hypomelanotic M... Plaque | NPC-12G gel Placebo gel | 3 Years - | Nobelpharma | |
| Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor | NCT00314262 | Precancerous Co... | Erlotinib & Cel... | 18 Years - 65 Years | Emory University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
